Anthony J. Giovinazzo
About Anthony J. Giovinazzo
Anthony J. Giovinazzo: Director, Governance/Nominating Committee Chair
Anthony J. Giovinazzo serves as the Director and Governance/Nominating Committee Chair at Sublimity Therapeutics. This private, late clinical stage biopharmaceutical company focuses on developing treatments for gastrointestinal and autoimmune diseases. In his role, Giovinazzo brings a wealth of experience in corporate governance and strategic oversight.
Anthony J. Giovinazzo's Role at Sublimity Therapeutics
Anthony J. Giovinazzo currently holds the position of Director and Executive Chairman on the board of Sublimity Therapeutics. The company specializes in addressing gastrointestinal and autoimmune diseases through innovative biopharmaceutical solutions. Giovinazzo's strategic leadership helps guide the company's direction and governance.
Anthony J. Giovinazzo: Co-Inventor of FDA Approved Drug Kynmobi
Anthony J. Giovinazzo is a co-inventor of Kynmobi, an FDA-approved drug. This medication has been recognized for its therapeutic impact, showcasing Giovinazzo's contribution to advancing medical treatments and pharmaceuticals.
Anthony J. Giovinazzo's Leadership at Cynapsus Therapeutics
Anthony J. Giovinazzo was the CEO and a director at Cynapsus Therapeutics Inc. until its acquisition by Sunovion Pharmaceuticals Inc. for CAD $841 million. His leadership at Cynapsus was instrumental in the company's successful growth and eventual acquisition, underscoring his capability in steering companies towards substantial achievements.
Anthony J. Giovinazzo's Educational Background
Anthony J. Giovinazzo holds a Chartered Director (C.Dir.) and Audit Committee Certification (ACC) from The Directors College and the DeGroote School of Business at McMaster University. Additionally, he earned a Bachelor of Arts degree in Economics and Accounting from McMaster University and an MBA from IMD in Geneva, Switzerland. These qualifications highlight his strong foundation in both corporate governance and business management.
Anthony J. Giovinazzo: Recipient of the Bloom Burton Award
In 2017, Anthony J. Giovinazzo was the inaugural recipient of the Bloom Burton Award. This award recognizes his significant achievements and contributions to the biopharmaceutical industry. Giovinazzo's receipt of this award highlights his influential role and impact within the sector.